Clinical Trial Update: A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dosing, effectiveness, and safety of topiramate for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Seizures
• Partial Seizures

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Seizures | Phase 4 | Status: COMPLETED